ConductScience.org, home

Paper412450

Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.

Khairi MR and 5 others. Ann Intern Med, 1977. Cited by 149 papers, by iCite.

Cite this record

ConductScience Library. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Papers, record 412450. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412450

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
PubMed
Journal
Ann Intern Med
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
149
iCite
Relative citation ratio, by iCite
6.28
iCite
Revised in PubMed
2019-06-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khairi MRM R
2Altman RDR D
3DeRosa GPG P
4Zimmermann JJ
5Schenk RKR K
6Johnston CCC C

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Etidronic AcidMajor topic
Osteitis DeformansMajor topic
Adult
Aged
Alkaline Phosphatase
Bone Matrix
Bone and Bones
Clinical Trials as Topic
Female
Fractures, Bone
Gastrointestinal Diseases
Humans
Hydroxyproline
Male
Middle Aged
Osteoblasts
Osteoclasts
Pain
Remission, Spontaneous
Risk
Time Factors

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.

PMIDTitleJournalYearIn PapersSource
32714279A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32714279PubMed
31848640Management of Paget's disease of bone.Osteoporos Int2020https://conductscience.org/library/papers/31848640PubMed
29192423Bisphosphonates for Paget's disease of bone in adults.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29192423PubMed
27562569Arterial calcification due to CD73 deficiency (ACDC): imaging manifestations of ectopic mineralization.Skeletal Radiol2016https://conductscience.org/library/papers/27562569PubMed
23327798Skeletal metastasis: treatments, mouse models, and the Wnt signaling.Chin J Cancer2013https://conductscience.org/library/papers/23327798PubMed
19652650Paget disease: when to treat and when not to treat.Nat Rev Rheumatol2009https://conductscience.org/library/papers/19652650PubMed
18504638Management of patients with Paget's disease: a consensus document of the Belgian Bone Club.Osteoporos Int2008https://conductscience.org/library/papers/18504638PubMed
16937267Guidelines for diagnosis and management of Paget's disease of bone in Japan.J Bone Miner Metab2006https://conductscience.org/library/papers/16937267PubMed
10647976Drug-induced diarrhoea.Drug Saf2000https://conductscience.org/library/papers/10647976PubMed
9122100Paget's disease of bone.Postgrad Med J1997https://conductscience.org/library/papers/9122100PubMed
7506648Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.Drugs1993https://conductscience.org/library/papers/7506648PubMed
6809282Focal mineralization defect during disodium etidronate treatment of calcinosis.Calcif Tissue Int1982https://conductscience.org/library/papers/6809282PubMed
6793126Paget's disease of bone.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6793126PubMed
6791792Effect of sodium etidronate and phenytoin of Pagetic bone.Calcif Tissue Int1981https://conductscience.org/library/papers/6791792PubMed
6456054Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients.Calcif Tissue Int1981https://conductscience.org/library/papers/6456054PubMed
6442196Monitoring the treatment of Paget's disease with etidronate.Calcif Tissue Int1984https://conductscience.org/library/papers/6442196PubMed
3928323Paget's disease of bone. An update on management.Drugs1985https://conductscience.org/library/papers/3928323PubMed
3918513Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.Ann Rheum Dis1985https://conductscience.org/library/papers/3918513PubMed
3107689Treating Paget's disease.Br Med J (Clin Res Ed)1987https://conductscience.org/library/papers/3107689PubMed
3090346[Diphosphonate for the prevention of an increased ossification process].Klin Wochenschr1986https://conductscience.org/library/papers/3090346PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/412450

GET https://conductscience.org/api/papers/v1/412450/cited_by?page=2